Lubrizol launches women’s nutrition resource

Lubrizol has launched an online women’s nutrition resource designed to help formulators, scientists, and brand teams match life-stage health needs with nutraceutical ingredient technologies.

The interactive, persona-based platform covers women’s nutritional requirements from adolescence through pregnancy, active adult life, middle age, menopause, and beyond. It presents ingredient options through five female personas, each linked to a specific health challenge and formulation route.

The platform includes Lipofer microcapsules, a microencapsulated iron ingredient positioned for women at risk of iron deficiency associated with menstruation and for pregnancy-related supplementation. Lubrizol has designed the ingredient to be water-dispersible, with improved bioavailability and stability, while addressing the texture and taste issues commonly associated with iron formats.

Curcushine microcapsules are presented for beauty-from-within applications. The ingredient uses microencapsulation to make curcumin water-dispersible and bioavailable while reducing its characteristic flavour profile. The format is aimed at applications such as beverages, gummies, powders, and other on-the-go products.

Magshape microcapsules address magnesium delivery for women seeking support around relaxation, stress, energy, and sleep quality. Conventional magnesium salts can carry off-tastes and tolerability issues, while Lubrizol’s microencapsulated magnesium oxide is positioned around higher bioavailability, reduced gastric side effects, and more flexible delivery formats.

For menopause and post-menopause support, the resource highlights Lipophytol microcapsules, a microencapsulated plant sterol ingredient designed for cardiovascular health applications. Its water-dispersible and concentrated format is intended to support incorporation into everyday food and beverage products.

The launch sits within a growing women’s health and nutraceuticals market. Demand is moving beyond single-issue supplement positioning and into more segmented life-stage products, with consumers expecting stronger substantiation, better sensory quality, and convenient formats.

The formulation challenge is considerable. Ingredients such as iron, curcumin, magnesium, and plant sterols can be technically difficult to deliver in appealing formats. Taste, solubility, stability, bioavailability, dose size, and gastrointestinal tolerability all affect whether a product can move from concept to repeat purchase.

Microencapsulation is central to Lubrizol’s approach because it addresses several of those issues at once. By protecting active ingredients and modifying how they disperse, taste, and perform in finished products, encapsulation can widen the range of viable formats. Gummies, beverages, powders, chews, and functional snacks continue to take share from traditional tablets and capsules.

The resource also shows the shift in nutrition innovation from broad demographic positioning to more precise need states. Women’s health is increasingly segmented around menstruation, pregnancy, skin health, stress, active lifestyles, menopause, and cardiovascular risk. That creates room for more relevant products while raising expectations around evidence, claims discipline, and responsible communication.

Functional products also have to be enjoyable. A nutraceutical that tastes metallic, bitter, chalky, or medicinal is unlikely to gain mainstream traction, regardless of its technical merit. Sensory performance is becoming part of ingredient selection rather than a late-stage flavour-masking exercise.

Lubrizol’s platform connects ingredient technology with product development by linking specific women’s health needs to microencapsulated ingredients that can be built into scalable formats. The next phase of women’s nutrition will be shaped by products that combine credible evidence, clear positioning, and manufacturing practicality.